Registry for patients with portal hypertension undergoing TIPS
Official title: Österreichisches Register (inklusive Biobank) Für Transjuguläre Intrahepatische Portosystemischem Shunts (TIPS): AUTIPS (AUstrian TIPS Study)
Run by Medical University of Vienna · NCT03409263 · Data updated 2026-11-12
This study is looking at patients with serious liver disease who have had a specific procedure called TIPS to see how they do afterwards and if certain markers can help predict any problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna, State of Vienna) |
| Status | Recruiting |
| Started | March 28, 2018 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | November 6, 2024 |
| Trial ID | NCT03409263 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-99 with portal hypertension who are anticipated to undergo or have previously undergone TIPS implantation.
✕Probably not a fit
Patients who retract their consent or do not meet the eligibility criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry study aims to recruit patients with advanced chronic liver disease who are undergoing or have undergone transjugular intrahepatic portosystemic shunt (TIPS) implantation. The study will document the clinical course of these patients and assess biomarkers that may predict complications following the procedure. By collecting and analyzing this data, the study seeks to improve understanding of long-term outcomes associated with TIPS and enhance patient management strategies.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and management of complications in patients with portal hypertension undergoing TIPS.
How similar studies have gone: While there have been studies on TIPS, this registry approach focusing on long-term outcomes and biomarkers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-99 years * Portal hypertension * Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS) * Informed consent Exclusion Criteria: * Retraction of consent
Where it's running
-
Medical University of Vienna
Vienna, State of Vienna, Austria Recruiting
Study contacts
- Principal investigator: Thomas Reiberger, MD — Medical University of Vienna
- Study coordinator: Thomas Reiberger, MD
- Email: thomas.reiberger@meduniwien.ac.at
- Phone: +43140400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endohepatology-based reclassification of treatment indication in high-risk MASLD
This study tests whether an endohepatology assessment can change treatment decisions for adults with high-risk MASLD.
-
Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
4D-Flow MRI to see portal hypertension and TIPS outcomes in cirrhosis
This study tests a noninvasive 4D-Flow MRI method to see if it can safely and reliably reflect portal hypertension and predict outcomes for people with cirrhosis, including those needing a TIPS procedure.
-
Apixaban plus carvedilol to prevent portal-hypertension complications in cirrhosis
This will test whether adding apixaban to carvedilol can help prevent variceal bleeding, portal vein thrombosis, and other portal-hypertension complications in adults with Child-Pugh B cirrhosis.
-
Blood clotting and portal vein changes during TIPS placement in cirrhosis
This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.